Lack of Tolerance Development after Long-Term Administration of the Partial Beta-Adrenoceptor Agonist Xamoterol

Xamoterol is a selective partial β-adrenoceptor agonist. In a double-blind randomized placebo-controlled study, 30 patients (1 female, 29 male) with mild to moderate heart failure were treated with 20